Loading...
Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice
Plasminogen activator inhibitor 1 (PAI‐1), an essential regulator of fibrinolysis, is increasingly implicated in the pathogenesis of metabolic disorders, such as obesity and nonalcoholic fatty liver disease (NAFLD). Pharmacologic inhibition of PAI‐1 is emerging as a highly promising therapeutic stra...
Na minha lista:
| Udgivet i: | Hepatol Commun |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6287480/ https://ncbi.nlm.nih.gov/pubmed/30556037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1259 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|